首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Combined molecular dynamics, STD-NMR, and CORCEMA protocol yields structural model for a UDP-galactopyranose mutase-inhibitor complex
【24h】

Combined molecular dynamics, STD-NMR, and CORCEMA protocol yields structural model for a UDP-galactopyranose mutase-inhibitor complex

机译:结合分子动力学,STD-NMR和CORCEMA方案可得出UDP-吡喃半乳糖突变酶抑制剂复合物的结构模型

获取原文
获取原文并翻译 | 示例
           

摘要

UDP-galactopyranose mutase (UGM) is an enzyme involved in the biosynthesis of the Mycobacterium tuberculosis cell wall, and is essential for the growth and survival of the organism. A micromolar inhibitor developed by tetrafluorination of the UGM substrate has been previously studied by saturation transfer difference (STD) NMR spectroscopy. To elucidate the bioactive conformation of the inhibitor bound to UGM, we employ molecular dynamics (MD) simulations to construct a structural model. The MD model is subsequently validated by a good fit between experimental and theoretical STD effects, the latter calculated by a complete relaxation and conformational exchange matrix (CORCEMA) analysis. This structural model is used to explain the relative binding affinities of the inhibitor and the parent substrate. (C) 2015 Elsevier Ltd. All rights reserved.
机译:UDP-吡喃半乳糖突变酶(UGM)是一种参与结核分枝杆菌细胞壁生物合成的酶,对于该生物的生长和存活至关重要。先前已通过饱和转移差异(STD)NMR光谱研究了UGM底物的四氟化物开发的微摩尔抑制剂。为了阐明与UGM结合的抑制剂的生物活性构象,我们采用分子动力学(MD)模拟来构建结构模型。随后通过实验性和理论性STD效应之间的良好拟合来验证MD模型,后者通过完整的松弛和构象交换矩阵(CORCEMA)分析来计算。该结构模型用于解释抑制剂和母体底物的相对结合亲和力。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号